231 related articles for article (PubMed ID: 18650184)
1. Successful autologous peripheral blood stem cell transplantation for a patient with primary adrenal lymphoma with hemophagocytic syndrome.
Uehara T; Yokota A; Onoda M; Yamamoto K; Terano T
Clin Lymphoma Myeloma; 2008 Jun; 8(3):184-7. PubMed ID: 18650184
[TBL] [Abstract][Full Text] [Related]
2. [Effective combined modality therapy for a patient with primary adrenal lymphoma].
Shirao S; Kuroda H; Kida M; Watanabe H; Matsunaga T; Niitsu Y; Konuma Y; Hirayama Y; Kohda K
Rinsho Ketsueki; 2006 Mar; 47(3):204-9. PubMed ID: 16629485
[TBL] [Abstract][Full Text] [Related]
3. [A case of primary testicular diffuse large B-cell lymphoma with a p53 gene point mutation].
Usami M; Kuroda H; Shimoyama S; Yoshida M; Yamada M; Abe T; Sakurai T; Fujii S; Maeda M; Wakabayashi Y; Tsukamoto K; Fujita M; Kanari Y; Takada K; Kato J
Gan To Kagaku Ryoho; 2015 May; 42(5):613-6. PubMed ID: 25981657
[TBL] [Abstract][Full Text] [Related]
4. [Combined modality therapy for a patient with primary adrenal lymphoma].
Matsuno T; Kuroda H; Jomen W; Yoshida M; Yamada M; Sato M; Abe T; Sakurai T; Fujii S; Maeda M; Fujita M; Nagashima K; Nojiri S; Arihara Y; Kato J
Gan To Kagaku Ryoho; 2014 Apr; 41(4):509-12. PubMed ID: 24743371
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of post-remission therapy using (90)yttrium ibritumomab tiuxetan (Zevalin®) for high-risk patients with diffuse large B-cell lymphoma.
Han EJ; Lee SE; Kim SH; Sohn HS; Jung SE; Park G; Choi BO; Lee SN; Yang SW; Han K; Cho SG
Ann Hematol; 2011 Sep; 90(9):1075-82. PubMed ID: 21336624
[TBL] [Abstract][Full Text] [Related]
6. Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma.
Kamezaki K; Kikushige Y; Numata A; Miyamoto T; Takase K; Henzan H; Aoki K; Kato K; Nonami A; Kamimura T; Arima F; Takenaka K; Harada N; Fukuda T; Hayashi S; Ohno Y; Eto T; Harada M; Nagafuji K
Bone Marrow Transplant; 2007 May; 39(9):523-7. PubMed ID: 17369863
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment with autologous peripheral blood stem cell transplantation for acquired immunodeficiency syndrome (AIDS)-related malignant lymphoma.
NAGAI Y; MORI M; INOUE D; KIMURA T; SHIMOJI S; TOGAMI K; TABATA S; MATSUSHITA A; NAGAI K; Imai Y; Takafuta T; Takahashi T
Rinsho Ketsueki; 2009 Nov; 50(11):1641-6. PubMed ID: 20009441
[TBL] [Abstract][Full Text] [Related]
8. Primary bilateral adrenal lymphoma revealed by hemophagocytic syndrome.
Alaoua A; Gilbert G; Ghannouchi N; Houchlef M; Letaief A; Bahri F
Ann Endocrinol (Paris); 2011 Jun; 72(3):247-50. PubMed ID: 21640976
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
Nonami A; Takenaka K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M
Int J Hematol; 2007 Apr; 85(3):264-6. PubMed ID: 17483065
[TBL] [Abstract][Full Text] [Related]
10. Primary adrenal lymphoma presenting as adrenal insufficiency. A case report and review of literature.
Zar T; Khan F; Petit W; Bernene JR
Conn Med; 2004 Jan; 68(1):7-10. PubMed ID: 14752912
[TBL] [Abstract][Full Text] [Related]
11. A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
Coso D; Sebban C; Boulat O; Biron P; Rey J; Aurran T; Chabannon C; Xerri L; Chetaille B; Esterni B; Ivanov V; Stoppa AM; Schiano de Collela JM; Gastaut JA; Maraninchi D; Bouabdallah R
Bone Marrow Transplant; 2006 Aug; 38(3):217-22. PubMed ID: 16770316
[TBL] [Abstract][Full Text] [Related]
12. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Kanaji N; Ishibashi K; Uno H; Hino N
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
[TBL] [Abstract][Full Text] [Related]
13. Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era.
Biswas T; Dhakal S; Chen R; Hyrien O; Bernstein S; Friedberg JW; Fisher RI; Liesveld J; Phillips G; Constine LS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):79-85. PubMed ID: 19647953
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy with autologous stem cell transplantation following systemic chemotherapy, prophylactic intrathecal methotrexate, and radiotherapy prevents relapse and improves the outcome of advanced stage primary testicular lymphoma even with cardiac involvement.
Lee S; Yamauchi T; Kinoshita K; Imamura S; Kamiya K
J Clin Exp Hematop; 2017 Oct; 57(2):64-68. PubMed ID: 28883219
[TBL] [Abstract][Full Text] [Related]
15. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
[TBL] [Abstract][Full Text] [Related]
16. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
Pfreundschuh M; Kuhnt E; Trümper L; Osterborg A; Trneny M; Shepherd L; Gill DS; Walewski J; Pettengell R; Jaeger U; Zinzani PL; Shpilberg O; Kvaloy S; de Nully Brown P; Stahel R; Milpied N; López-Guillermo A; Poeschel V; Grass S; Loeffler M; Murawski N;
Lancet Oncol; 2011 Oct; 12(11):1013-22. PubMed ID: 21940214
[TBL] [Abstract][Full Text] [Related]
17. Primary bilateral adrenal diffuse large B-cell lymphoma demonstrating adrenal failure.
Horiguchi K; Hashimoto K; Hashizume M; Masuo T; Suto M; Okajo J; Handa H; Kaneko Y; Yokoo H; Sasaki A; Okada S; Yamada M; Tsukamoto N; Nojima Y; Nakazato Y; Mori M
Intern Med; 2010; 49(20):2241-6. PubMed ID: 20962443
[TBL] [Abstract][Full Text] [Related]
18. Patients with diffuse large B cell lymphoma in partial response or stable disease after first-line R-CHOP: the prognostic value of the absolute lymphocyte count and impact of autologous stem cell transplantation.
Hung MH; Yu YB; Huang YC; Liu HT; Hong YC; Hsiao LT; Liu JH; Gau JP; Chiou TJ; Chen PM; Tzeng CH; Liu CY
Ann Hematol; 2012 Dec; 91(12):1907-15. PubMed ID: 22885989
[TBL] [Abstract][Full Text] [Related]
19. [Autologous peripheral blood stem cell transplantation for CHOP-resistant mediastinal diffuse large B-cell lymphoma].
Kawabata Y; Hirokawa M; Horiuchi T; Hatakeyama T; Kobayashi Y; Saito K; Kume M; Nimura T; Nishinari T; Miura AB
Rinsho Ketsueki; 1997 Aug; 38(8):674-81. PubMed ID: 9311274
[TBL] [Abstract][Full Text] [Related]
20. A long-lasting third complete remission after second autologous transplant followed by maintenance treatment with rituximab in a patient with diffuse large cell non-Hodgkin's lymphoma.
Ataergin S; Arpaci F; Beyzadeoglu M; Safali M; Ozet A
Am J Hematol; 2006 Dec; 81(12):986-7. PubMed ID: 16886214
[No Abstract] [Full Text] [Related]
[Next] [New Search]
